RGC
Regencell Bioscience Holdings Limited
$16.65
+$0.30(+1.83%)
49
Overall
--
Value
63
Tech
36
Quality
Market Cap
$8.54B
Volume
60.81K
52W Range
$0.09 - $83.60
Target Price
$NaN
Order:
Income Statement
| Metric | Trend | Chart | 2021 Jun | 2022 Jun | 2023 Jun | 2024 Jun |
|---|---|---|---|---|---|---|
| OPERATING EXPENSES | ||||||
| Operating Expenses | $1.4M | $7.6M | $6.3M | $4.7M | ||
| Research & Development | $438.3K | $2.5M | $1.6M | $1.1M | ||
| Research Expense | $438.3K | $2.5M | $1.6M | -- | ||
| Selling, General & Administrative | $943.0K | $5.1M | $4.7M | $3.7M | ||
| Selling & Marketing Expenses | $1.6K | $25.3K | $262.7K | $125.4K | ||
| General & Administrative Expenses | $941.5K | $5.1M | $4.4M | $3.5M | ||
| Salaries & Wages | -- | $-2.8M | -- | -- | ||
| Depreciation & Amortization | $-26.5K | -- | -- | -- | ||
| Depreciation & Amortization | $-26.5K | -- | -- | -- | ||
| OPERATING INCOME | ||||||
| Operating income | $-1.4M | $-7.6M | $-6.3M | $-4.7M | ||
| EBITDA | $-1.3M | $-7.0M | $-5.3M | $-3.6M | ||
| NON-OPERATING ITEMS | ||||||
| Other Income/Expense | $-34.6K | $23.2K | $-211.3K | $-373.5K | ||
| Other Special Charges | $34.6K | $23.2K | $211.3K | $373.5K | ||
| PRE-TAX INCOME | ||||||
| EBIT | $-1.3M | $-7.6M | $-6.1M | $-4.4M | ||
| Pre-Tax Income | $-1.3M | $-7.6M | $-6.1M | $-4.4M | ||
| NET INCOME | ||||||
| Net Income | $-1.3M | $-7.4M | $-5.9M | $-4.3M | ||
| Net Income (Continuing Operations) | $-1.3M | $-7.6M | $-6.1M | $-4.4M | ||
| Net Income (Discontinued Operations) | $-1.3M | $-7.4M | $-5.9M | $-4.3M | ||
| Net Income (Common Stockholders) | $-1.3M | $-7.4M | $-5.9M | $-4.3M | ||
| Normalized Income | -- | -- | $-4.5M | $-4.3M | ||
| TOTALS | ||||||
| Total Expenses | $1.4M | $7.6M | $6.3M | $4.7M | ||
| SHARE & EPS DATA | ||||||
| Average Shares Outstanding | $380.0M | $12.8M | $13.0M | $13.0M | ||
| Average Shares Outstanding (Diluted) | -- | $12.8M | $13.0M | $13.0M | ||
| Shares Outstanding | $380.0M | $13.0M | $494.5M | $494.5M | ||
| Basic EPS | $-0.13 | $-0.58 | $-0.45 | $-0.33 | ||
| Basic EPS (Continuing Operations) | -- | -- | $-0.45 | $-0.33 | ||
| Diluted EPS | -- | $-0.58 | $-0.45 | $-0.33 | ||
| Diluted EPS (Continuing Operations) | -- | -- | $-0.45 | $-0.33 | ||
| OTHER METRICS | ||||||
| Minority Interests | $1.4M | -- | $191.2K | $61.4K | ||
| Other Gand A | $941.5K | $5.1M | $4.4M | $3.5M | ||
| Rent And Landing Fees | $-167.2K | $5.1M | -- | -- | ||
| Selling Expense | $1.6K | $25.3K | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RGC | $16.65 | +1.8% | 60.81K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Regencell Bioscience Holdings Limited Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW